Torrent Pharmaceuticals informs about press release

11 Jul 2019 Evaluate

Torrent Pharmaceuticals has informed that the Company and Glenmark Pharmaceuticals have signed licensing agreement for co-marketing of Remogliflozin Etabonate in India. A Press release, containing the transaction details, which is being submitted to the media is enclosed herewith for information and record.

The above information is a part of company’s filings submitted to BSE.

Torrent Pharma Share Price

3926.95 -97.05 (-2.41%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×